Cyclooxygenase-2 (Cox-2) Expression in Lymphomas
- 1 July 2004
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (7) , 1395-1399
- https://doi.org/10.1080/10428190310001654032
Abstract
(2004). Cyclooxygenase-2 (Cox-2) Expression in Lymphomas. Leukemia & Lymphoma: Vol. 45, No. 7, pp. 1395-1399.Keywords
This publication has 17 references indexed in Scilit:
- Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Non-Hodgkin lymphomaThe Lancet, 2003
- Therapeutic Potential of Selective Cyclooxygenase-2 Inhibitors in the Management of Tumor AngiogenesisPublished by S. Karger AG ,2003
- Vascular Endothelial Growth Factor Signaling Pathway as an Emerging Target in Hematologic MalignanciesThe Oncologist, 2001
- Host cyclooxygenase-2 modulates carcinoma growthJournal of Clinical Investigation, 2000
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Expression of vascular endothelial growth factor in lymphomas and castleman's diseaseThe Journal of Pathology, 1997
- Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potentialProceedings of the National Academy of Sciences, 1997
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994